Erythroferrone may function as negative regulator of bone remodeling in beta-thalassemia

ORLANDO — Erythroferrone appeared to function as a negative regulator of osteoblast and osteoclast activity, and its loss can result in decreased bone mineral density in beta-thalassemia, according to results of a study presented during the plenary session of ASH Annual Meeting and Exposition. The findings may provide new insights into the interaction between regulation of iron metabolism

Read the full article here

Related Articles